BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11035725)

  • 21. Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response.
    Fidel PL; Murphy JW
    Infect Immun; 1990 Feb; 58(2):393-8. PubMed ID: 2105273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoadsorption of Cryptococcus-specific suppressor T-cell factors.
    Mosley RL; Murphy JW; Cox RA
    Infect Immun; 1986 Mar; 51(3):844-50. PubMed ID: 2936685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response.
    Murphy JW
    Infect Immun; 1993 Nov; 61(11):4750-9. PubMed ID: 8406874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
    Dong ZM; Murphy JW
    Infect Immun; 1995 Mar; 63(3):770-8. PubMed ID: 7868246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of two novel cryptococcal mannoproteins recognized by immune sera.
    Biondo C; Messina L; Bombaci M; Mancuso G; Midiri A; Beninati C; Cusumano V; Gerace E; Papasergi S; Teti G
    Infect Immun; 2005 Nov; 73(11):7348-55. PubMed ID: 16239533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.
    Huang C; Nong SH; Mansour MK; Specht CA; Levitz SM
    Infect Immun; 2002 Oct; 70(10):5485-93. PubMed ID: 12228274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans.
    Levitz SM; Nong S; Mansour MK; Huang C; Specht CA
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10422-7. PubMed ID: 11504924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenic fractions of Cryptococcus neoformans.
    Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
    Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with Recombinant
    Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor.
    Fidel PL; Murphy JW
    Infect Immun; 1988 May; 56(5):1267-72. PubMed ID: 2965681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Cryptococcus neoformans-specific suppressor T cells on the amplified anticryptococcal delayed-type hypersensitivity response.
    Buchanan KL; Fidel PL; Murphy JW
    Infect Immun; 1991 Jan; 59(1):29-35. PubMed ID: 1824761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response.
    McGaha T; Murphy JW
    Infect Immun; 2000 Aug; 68(8):4624-30. PubMed ID: 10899865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.
    Pietrella D; Mazzolla R; Lupo P; Pitzurra L; Gomez MJ; Cherniak R; Vecchiarelli A
    Infect Immun; 2002 Dec; 70(12):6621-7. PubMed ID: 12438334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.
    Murphy JW; Cox RA
    Clin Exp Immunol; 1988 Aug; 73(2):174-80. PubMed ID: 2460273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.
    Zhu Y; Yang C; Magee DM; Cox RA
    Infect Immun; 1996 Jul; 64(7):2695-9. PubMed ID: 8698497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.
    Lim TS; Murphy JW; Cauley LK
    Infect Immun; 1980 Aug; 29(2):633-41. PubMed ID: 7011980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of experimental nephrosis by culture filtrate of Cryptococcus neoformans var. gattii (CneF).
    Mirshafiey A; Razavi A; Mehrabian F; Moghaddam MR; Hadjavi M
    Immunopharmacol Immunotoxicol; 2002 Aug; 24(3):349-64. PubMed ID: 12375733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans.
    Hay RJ; Reiss E
    Infect Immun; 1978 Oct; 22(1):72-9. PubMed ID: 365751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of an immunogenic cellulase secreted by Cryptococcus pathogens.
    Midiri A; Mancuso G; Lentini G; Famà A; Galbo R; Zummo S; Giardina M; De Gaetano GV; Teti G; Beninati C; Biondo C
    Med Mycol; 2020 Nov; 58(8):1138-1148. PubMed ID: 32246714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells.
    Murphy JW; Mosley RL; Moorhead JW
    J Immunol; 1983 Jun; 130(6):2876-81. PubMed ID: 6222119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.